Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
NCT00934427
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Raynaud Disease
Interventions
DRUG:
0.9% nitroglycerin in TAM cream
DRUG:
vehicle cream
Sponsor
MediQuest Therapeutics